CP
DXCM icon

Covenant Partners’s DexCom DXCM Stock Holding History

Covenant Partners’s Portfolio DXCM Stock Details DXCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-2,931
Closed -$256K – 139
2025
Q2 		$256K Buy
+2,931
New +$230K 0.08% 121
2023
Q3 		– Sell
-4,290
Closed -$551K – 186
2023
Q2 		$551K Buy
4,290
+108
+3% +$13.1K 0.2% 87
2023
Q1 		$486K Buy
4,182
+92
+2% +$10.3K 0.19% 91
2022
Q4 		$463K Buy
4,090
+257
+7% +$28.2K 0.19% 95
2022
Q3 		$309K Buy
+3,833
New +$325K 0.15% 124
2022
Q2 		– Sell
-3,220
Closed -$412K – 184
2022
Q1 		$412K Sell
3,220
-136
-4% -$14.9K 0.16% 124
2021
Q4 		$451K Hold
3,356
– – 0.17% 128
2021
Q3 		$459K Hold
3,356
– – 0.18% 116
2021
Q2 		$358K Buy
+3,356
New +$322K 0.14% 151

Other funds holding DXCM

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $481B AUM 26.39% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
N
Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Covenant Partners's DXCM Position: Q3 2025 in Review

Covenant Partners sold out of DexCom (DXCM) in Q3 2025, closing a stake of 2,931 shares — an estimated $256K sold.

Covenant Partners first reported a position in DXCM in Q2 2021 and held it in 9 quarters. The position peaked at $551K in Q2 2023. 910 funds tracked by Wall St. Rank hold DXCM as of Q3 2025.

  • Covenant Partners reported no remaining DexCom position as of Q3 2025 after selling out during the quarter.
  • Covenant Partners sold 2,931 DexCom shares in Q3 2025, an estimated $256K.
  • Covenant Partners first reported a position in DexCom in Q2 2021 and held it in 9 quarters.
  • Covenant Partners's DexCom position peaked at $551K in Q2 2023.
  • 910 funds tracked by Wall St. Rank held DexCom as of Q3 2025.

Based on Covenant Partners's 13F filing for Q3 2025, filed 24 Oct 2025.